Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Net Margin (2017 - 2025)

Selectis Health's Net Margin history spans 14 years, with the latest figure at 8.39% for Q4 2025.

  • Quarterly results put Net Margin at 8.39% for Q4 2025, down 285.0% from a year ago — trailing twelve months through Dec 2025 was 2.54% (up 365.0% YoY), and the annual figure for FY2025 was 2.54%, up 365.0%.
  • Net Margin for Q4 2025 was 8.39% at Selectis Health, down from 6.87% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 41.83% in Q1 2023 to a low of 39.56% in Q4 2023.
  • The 5-year median for Net Margin is 7.39% (2025), against an average of 6.34%.
  • The sharpest move saw Net Margin skyrocketed 3956bps in 2023, then tumbled -5281bps in 2024.
  • Year by year, Net Margin stood at 17.64% in 2021, then fell by -15bps to 20.37% in 2022, then tumbled by -94bps to 39.56% in 2023, then soared by 86bps to 5.54% in 2024, then tumbled by -51bps to 8.39% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 8.39%, 6.87%, and 3.02% for Q4 2025, Q3 2025, and Q2 2025 respectively.